This grant from the Clinical and Translational Science Award (CTSA) Program aims to support collaborative research projects that develop innovative solutions enhancing the translation of observations into interventions for better health outcomes. It encourages researchers from multiple CTSA Program hub institutions to form new collaborations, expand existing ones, or engage new collaborators to address research goals. The funding opportunity focuses on promoting highly innovative and exploratory projects within the CTSA Program to evaluate the feasibility and utility of proposed innovations. Application deadline: November 9, 2021.
Opportunity ID: 311067
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-100 |
| Funding Opportunity Title: | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.350 — National Center for Advancing Translational Sciences |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 12, 2018 |
| Last Updated Date: | Dec 12, 2018 |
| Original Closing Date for Applications: | Nov 09, 2021 |
| Current Closing Date for Applications: | Nov 09, 2021 |
| Archive Date: | Dec 15, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See FOA for full eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from two or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA. The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, and collaborative research projects in the CTSA Program, with the goal of assessing utility and feasibility of proposed innovation(s). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-100.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00246813 | Feb 08, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259779 | Feb 08, 2019 | Jan 24, 2022 | View |
Package 1
Mandatory forms
311067 RR_SF424_2_0-2.0.pdf
311067 PHS398_CoverPageSupplement_4_0-4.0.pdf
311067 RR_OtherProjectInfo_1_4-1.4.pdf
311067 PerformanceSite_2_0-2.0.pdf
311067 RR_KeyPersonExpanded_2_0-2.0.pdf
311067 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
311067 RR_Budget_1_4-1.4.pdf
311067 RR_SubawardBudget30_1_4-1.4.pdf
311067 PHS398_ModularBudget_1_2-1.2.pdf
311067 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
311067 RR_SF424_2_0-2.0.pdf
311067 PHS398_CoverPageSupplement_5_0-5.0.pdf
311067 RR_OtherProjectInfo_1_4-1.4.pdf
311067 PerformanceSite_2_0-2.0.pdf
311067 RR_KeyPersonExpanded_2_0-2.0.pdf
311067 PHS398_ResearchPlan_4_0-4.0.pdf
311067 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
311067 RR_Budget_1_4-1.4.pdf
311067 RR_SubawardBudget30_1_4-1.4.pdf
311067 PHS398_ModularBudget_1_2-1.2.pdf
311067 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
